19
Jun
2024

Zhejiang Supor Pharmaceuticals Co., Ltd

Exhibitor at CPHI & PMEC China 2024 stand W2C30a, Pharma Ingredients
About Us

Supor Pharma is specialized in manufacturing of APIs, the facility has been approved by US FDA , EU EDQM , SFDA and other national authorities for several times. We supplied our products widely to domestic market and foreign market. All the commercial products are with DMF and we are experienced in  registration in global markets.

  • CN
  • 2015
    On CPHI since
Contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand W2C30a, Pharma Ingredients

Products Featured at CPHI & PMEC China 2024

  • quetiapine fumarate

    Product quetiapine fumarate

    This product is with US FDA and EU EDQM approvals, CEP, DMF, GMP and other international certificates are available.
  • bupropion HCL

    Product bupropion HCL

    This product has passed US FDA inspection, the DMF and other international certificates are available.
  • felodipine

    Product felodipine

    The product has been approved by US FDA, CEP DMF and GMP are available.
  • Tinidazole

    Product Tinidazole

    The product has been approved by US FDA and EU EDQM, local GMP , EU  GMP, CEP and DMF are available.
  • olanzapine

    Product olanzapine

    Zhejiang Supor Pharmaceuticals Co. Ltd offers a wide range of products which includes olanzapine. It belongs to API category. Contact us for more information.